Topic
panel
FDA Panel Endorses Unproven Peptides, Opening Door for Compounding Pharmacy Manufacturing
An FDA advisory panel voted 8-6 to recommend reclassifying three unproven peptides—BPC-157, KPV, and TB-500—allowing compounding pharmacies to produce them. A fourth peptide, MOTs-C, received a 7-5 vote in favor. The decision could reshape pharmaceutical manufacturing supply chains, as China and India are major suppliers of these peptides.
Panel to Examine Labour Market Metrics as India's Employment Landscape Evolves
The Indian statistics ministry has constituted a 22-member experts committee to review labour market metrics, focusing on informal employment, moonlighting, seasonal migration, and platform work. Chaired by IHD professor Alakh Sharma, the committee will assess existing indicators and suggest improvements, including demand-side metrics and alternative data sources.
Trade India Forms Panel to Address Demographic Changes from Immigration
India has established a high-level committee to assess demographic changes linked to illegal immigration. Chaired by Justice Naolekar, the panel aims to address national security concerns.